Max Robotics — Global Service Robot Directory + US Certification

About

Noriyasu Hagiwara is a pioneering urologic surgeon whose research is reshaping the surgical management of prostate and kidney cancers. His work centers on two critical frontiers: maximizing oncological control through robot-assisted radical prostatectomy (RARP) in metastatic prostate cancer, and preserving renal function through advanced partial nephrectomy techniques. Hagiwara’s most impactful study (9 citations) provides compelling evidence that cytoreductive RARP can improve outcomes for patients with metastatic prostate cancer—a paradigm shift from traditional palliative approaches. In renal cell carcinoma, he has systematically investigated how surgical technique affects kidney function, demonstrating that warm ischemic time and renorrhaphy method (single vs. double layer) significantly impact postoperative renal recovery. His multicenter cohort study on renorrhaphy techniques (5 citations) offers practical guidance for surgeons seeking to optimize nephron preservation. Hagiwara’s contributions are particularly notable for addressing challenging patient populations, including those with oligometastatic castration-resistant prostate cancer, where he has shown that local definitive therapy may reduce cancer-specific mortality. His work bridges the gap between aggressive surgical intervention and functional preservation, establishing evidence-based protocols that directly improve patient quality of life.